Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An acute biphenotypic leukemia that is characterized by blasts which express B-lymphoid and myeloid lineage markers but are negative for MLL translocation and t(9;22)(q34;q11.2) translocation.
Biomarker and diagnostic research for mixed phenotype acute leukemia, B/myeloid has been reported in the published literature.
No clinical trials have been registered for mixed phenotype acute leukemia, B/myeloid.
5 publications have been identified in PubMed for mixed phenotype acute leukemia, B/myeloid. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (40%), and Diagnostic / Biomarker (20%).
George GV (2025). [PMID: 40282530](https://pubmed.ncbi.nlm.nih.gov/40282530/). *Cancers (Basel)*. [Diagnostic / Biomarker]
Au WY (2025). [PMID: 39531055](https://pubmed.ncbi.nlm.nih.gov/39531055/). *Ann Hematol*. [Case Report / Case Series]
Wang YF (2025). [PMID: 40653706](https://pubmed.ncbi.nlm.nih.gov/40653706/). *Immunotherapy*. [Review / Meta-Analysis]
Sotolongo GL (2025). [PMID: 40982072](https://pubmed.ncbi.nlm.nih.gov/40982072/). *J Hematop*. [Case Report / Case Series]
Wang L (2024). [PMID: 38952502](https://pubmed.ncbi.nlm.nih.gov/38952502/). *Pak J Med Sci*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 3:33 AM UTC
AI-curated news mentioning mixed phenotype acute leukemia, B/myeloid
Updated Sep 2, 2026
A multi-center case series investigates clinical outcomes and molecular features of CEBPA-mutated mixed phenotype acute leukemia (MPAL). The findings contribute to understanding the disease's biology and potential treatment strategies.
A rare case report details mixed phenotype acute leukemia presenting symptoms similar to adult-onset Still's disease in a pregnant female. This case highlights the diagnostic challenges and the need for awareness of overlapping symptoms in rare diseases.